|
New HIV vaccine tested in macaques shows promising results. |
|
|
BBC: A new vaccine can protect macaques against the monkey equivalent of HIV and could provide a fresh approach to an HIV vaccine, a study suggests.
|
|
BMC Medical Ethics journal publishes report focused on dialysis patient scenarios. |
|
|
BMC Medical Ethics (Gronlund et al): Conclusion. The meanings of being in ethically difficult situations that led to the burden of a troubled conscience in those working in hemodialysis care, indicate the importance of increasing the level of communication within and among various professional groups - to transform being burdened by a troubled conscience into using conscience as a guide - in situations where no way of solving the problem seems to be good.
|
Nephros gets approval to market its dual stage ultrafilter in Canada. |
|
|
PrNewswire: Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that on May 10, 2011 the Company received approval from the Therapeutic Products Directorate of Health Canada, the Canadian health regulatory agency, to market its Dual Stage Ultrafilters (DSU) in Canada to filter out biological contaminants from water and bicarbonate solution used in hemodialysis procedures.
|
|
Five Star Healthcare offers insurance policy for dialysis unit providers. |
|
|
Gnome.es: Five Star Healthcare, a division of Crump Insurance Services, Inc., and part of Crump Group, Inc., the nation’s largest insurance wholesaler, today announced it has added a new insurance facility for Kidney Dialysis Centers.
|
Losartan might protect against disuse muscle atrophy (in mice). |
|
|
EurekAlert: Next, the researchers conducted disuse experiments to find out if losartan, in addition to improving muscle regeneration, might have even broader clinical applications in the protection against immobilization atrophy. Again, using 21-month-old mice, half treated with losartan and half not, the team this time clipped the hind right foot of the mice to their knees, immobilizing just the shin muscles; otherwise, the mice were normally active. After 21 days, the animals' shin muscles were weighed and compared under a microscope. The animals not treated with losartan lost 20 percent of the mass of their immobilized shin muscles. However, the losartan-treated animals lost virtually no mass, according to Tyesha Burks, a graduate student of Human Genetics, Johns Hopkins University School of Medicine. "When we saw that the loss of muscle fibers was completely prevented by losartan therapy, it was quite mind-blowing," Cohn says.
|
|
|
|
<< Start < Prev 911 912 913 914 915 916 917 918 919 920 Next > End >>
|
Page 911 of 2630 |